A research team led by Professor Zhou Xuyu from the Institute of Microbiology of the Chinese Academy of Sciences (CAS), in ...

ZHOU Xuyu from the Institute of Microbiology of the Chinese Academy of Sciences (CAS), in collaboration with researchers from Beijing Ditan Hospital and Capital Medical University, has identified ...

T-cell redirecting platforms function by enabling antigen-specific recognition or by colocalizing effector T cells with tumor ...

Blocking a tumor antioxidant restored T cell activity and made some resistant cancers more responsive to immunotherapy in ...

Immune cells can become exhausted after prolonged exposure to cancer, gradually losing their ability to attack tumor cells.

Using microscopic silicon nanowires, Singh and his team delivered the instructions into more than 90% of aging T cells without damaging them. The goal wasn't to reverse aging. It was to restore enough ...

After day 30, patients ≥65 years had greater transient physical-function worsening than younger patients, but age-related ...

The U.S. Food and Drug Administration (FDA) has granted fast-track designation to CK0803, an experimental T-cell therapy from Cellenkos that’s currently in Phase 1 clinical testing for people with ...